Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Continuously Improving Quality and Efficiency of AAV Manufacturing | Contract Pharma

What are you searching for?

Sign in
Posters

Continuously Improving Quality and Efficiency of AAV Manufacturing

Released By IDT Biologika

The field of AAV-based gene therapies is rapidly evolving. This applies to aspects such as manufacturing, analytics and regulations which are core competencies of IDT Biologika, a full-service CDMO specialized in virus-based therapies and vaccines.

In the following, we present insights into our cross-serotype, robust high-yield AAV manufacturing platform. The platform was established with the objective of providing short timelines and a cost-effective scalable process to produce clinical trial and commercial material in up to 2000-liter bioreactors. Current and future areas of process and analytical development are outlined in this presentation.

Download Posters Now

Download Posters Now

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics